newsfilter
← Latest News
GlobeNewswire·

Immunocore reports second quarter financial results and provides a business update

Immunocore reports second quarter financial results and provides a business update KIMMTRAK® (tebentafusp-tebn) net revenues of $115.9 million in Q2 2026, growing by 18% year-over-year Enrollment in Phase 3 TEBE-AM